Search Results 81-90 of 17212 for remdesivir

  1. Atrial Fibrillation Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  2. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

    hydroxychloroquine, azithromycin, remdesivir, anti-spike antibodies, and/or convalescent plasma are not excluded from the study. Participating Mayo Clinic ...

  3. COPD Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  4. Chronic Kidney Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  5. High Blood Pressure Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  6. High Blood Pressure Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  7. Emtricitabine, rilpivirine, and tenofovir (oral route) - Mayo Clinic

    HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients who have not received any HIV treatment in ...

  8. Doravirine, lamivudine, and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    Doravirine, lamivudine, and tenofovir combination is used to treat human immunodeficiency virus (HIV) infection in patients who have not been treated with ...

  9. Cystic Fibrosis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...

  10. Publications - Robert W. Kirchoff, M.D., M.S. - Mayo Clinic

    Kingsley R, Rohlman C, Chaudhary R, Phelan D, Kirchoff R. Cardiac Conduction Delay Associated With Remdesivir in COVID-19 Journal of Contemporary Pharmacy ...